A team of researchers have used targeted CRISPR screening and have identified PRMT5 as a synthetic lethality combinatorial target with […]
Researchers at the University of Texas have performed genome-wide CRISPR screens to uncover vulnerabilities critical for discovering anticancer drugs. The […]
Here we summarise a recent paper, published in Cell, that explored the landscape of therapeutic cancer targets beyond the list […]
Scientists have engineered human pancreatic cancer cells (Panc-1) to reprogram and revert them back to their normal state following PTF1A […]
